3 results
Not approvedWill not start
To assess impact of high doses vitamin D on tumour histology in breast cancer patients
Approved WMOCompleted
Dual Primary Objectives:* To determine if apixaban is noninferior to VKA (INR target range 2.0-3.0) on the combined endpoint of ISTHmajor or clinically relevant non-major bleeding in patients with NVAF who develop ACS or undergo PCI withplanned…
Approved WMOCompleted
To assess the effect of vitamin D supplementation on exacerbation rate in patients with COPD and a vitamin D deficiency.